SynthesisEuropean radiology2025
Complications in chemical and thermal ablation of parathyroid lesions: a systematic review and meta-analysis.
Synthesis in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy and safety of cooled and uncooled microwave ablation for the treatment of parathyroid adenomas.Irish journal of medical science · 2026Article
- Percutaneous Cryoablation of a Typical Parathyroid Adenoma: A Minimally Invasive Option.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMinimally invasive treatments such as ethanol ablation (EA), microwave ablation (MWA), and radiofrequency ablation (RFA) are options for parathyroid lesion treatment, especially in patients ineligible for or declining surgery. We aimed to assess the safety of minimally invasive treatments for parathyroid lesions. MATERIALS AND
methodsPubMed and Embase were searched for original literature published on or before September 27, 2023, and 34 studies with 2102 patients (12 EA, 1 laser ablation, 10 MWA, 10 RFA, 1 both EA and RFA) were included. The pooled incidence of complications associated with chemical or thermal ablation was calculated. Subgroup analyses were performed according to ablation method and type of hyperparathyroidism (primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism (SHPT)).
resultsThe overall pooled incidences of total, major, and minor complications were 19.1%, 5%, and 12.7%, respectively. Among complications, incidences of permanent and transient voice change were 2.7% and 8.9%, respectively. In subgroup analysis, the incidence of major complications was significantly higher in MWA than in EA or RFA (p = 0.032), whereas total and minor complications were higher in MWA than others, but there was no statistical significance. The pooled incidence of major complications was significantly higher in SHPT than in PHPT (1.9% vs.11.0%, p = 0.024).
conclusionsThe overall incidences of total, major, and minor complications were 19.1%, 5%, and 12.7%, respectively. Patients treated with MWA had a significantly higher incidence of major complications than patients treated with other methods. Patients with SHPT had a significantly higher incidence of major complications compared with patients with PHPT. KEY POINTS: Question What are the safety outcomes of minimally invasive treatments, including chemical or thermal ablation, for patients with parathyroid lesions? Findings Overall incidences of total, major, and minor complications were 19.1%, 5%, and 12.7%, and of permanent and transient voice change were 2.7% and 8.9%. Clinical relevance Microwave ablation demonstrated significantly higher major complication rates than other chemical or thermal ablation methods. Patients with secondary hyperparathyroidism showed significantly higher major complication rates than patients with primary hyperparathyroidism.
Indexed as
Identifiers
40481874What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.